Although tumor expression of the programmed death-1 ligand 1 (PD-L1) is predictive of the therapeutic response in certain tumor types such as melanoma and non-small cell lung cancer11–15, we found that PD-L1 expression alone was not sufficiently predictive of response in the case of ovarian cancer10,16. The gene discussed is CD274; the disease is neoplasm.